IO Biotech
Diane McDowell serves as Senior Vice President of Clinical Development and Medical Affairs at IO Biotech since October 2021, following a tenure as Corporate Vice President of Global Medical Affairs Oncology at Celgene from October 2018 to April 2021. Prior roles include Head of Global Scientific Affairs Oncology R&D at GSK and Head of U.S. Medical Affairs Oncology at Merck, where significant contributions included expanding teams and leading regulatory interactions. Diane's extensive experience encompasses various leadership positions in oncology clinical development and medical affairs, underscored by a strong educational background including a medical degree from Temple University and a fellowship in Breast Cancer from Fox Chase Cancer Center.
This person is not in any teams
This person is not in any offices
IO Biotech
2 followers
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.